{"id":"https://openalex.org/W2298692973","doi":"https://doi.org/10.1111/cas.12932","title":"Phase I study of palbociclib, a cyclin\u2010dependent kinase 4/6 inhibitor, in Japanese patients","display_name":"Phase I study of palbociclib, a cyclin\u2010dependent kinase 4/6 inhibitor, in Japanese patients","publication_year":2016,"publication_date":"2016-03-19","ids":{"openalex":"https://openalex.org/W2298692973","doi":"https://doi.org/10.1111/cas.12932","mag":"2298692973","pmid":"https://pubmed.ncbi.nlm.nih.gov/26991823","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4968608"},"language":"en","primary_location":{"id":"doi:10.1111/cas.12932","doi":"https://doi.org/10.1111/cas.12932","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.12932","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12932","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12932","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069272944","display_name":"Kenji Tamura","orcid":"https://orcid.org/0000-0002-3514-9927","observed_orcids":["https://orcid.org/0000-0002-3514-9927"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]},{"id":"https://openalex.org/I4405286036","display_name":"National Cancer Center Exploratory Oncology Research & Clinical Trial Center","ror":"https://ror.org/00zwh4w61","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kenji Tamura","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]},{"raw_affiliation_string":"Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089829213","display_name":"Hirofumi Mukai","orcid":"https://orcid.org/0000-0002-9292-5128","observed_orcids":["https://orcid.org/0000-0002-9292-5128"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirofumi Mukai","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064272098","display_name":"Yoichi Naito","orcid":"https://orcid.org/0000-0002-8490-9064","observed_orcids":["https://orcid.org/0000-0002-8490-9064"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]},{"id":"https://openalex.org/I4405286036","display_name":"National Cancer Center Exploratory Oncology Research & Clinical Trial Center","ror":"https://ror.org/00zwh4w61","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoichi Naito","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan","Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]},{"raw_affiliation_string":"Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021522674","display_name":"Kan Yonemori","orcid":"https://orcid.org/0000-0002-7624-7611","observed_orcids":["https://orcid.org/0000-0002-7624-7611"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kan Yonemori","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082725109","display_name":"Makoto Kodaira","orcid":"https://orcid.org/0000-0002-1977-0350","observed_orcids":["https://orcid.org/0000-0002-1977-0350"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Kodaira","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016197648","display_name":"Yuko Tanabe","orcid":"https://orcid.org/0000-0001-9279-5952","observed_orcids":["https://orcid.org/0000-0001-9279-5952"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405286036","display_name":"National Cancer Center Exploratory Oncology Research & Clinical Trial Center","ror":"https://ror.org/00zwh4w61","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuko Tanabe","raw_affiliation_strings":["Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030587345","display_name":"Noboru Yamamoto","orcid":"https://orcid.org/0000-0002-0787-2851","observed_orcids":["https://orcid.org/0000-0002-0787-2851"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]},{"id":"https://openalex.org/I4405286036","display_name":"National Cancer Center Exploratory Oncology Research & Clinical Trial Center","ror":"https://ror.org/00zwh4w61","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noboru Yamamoto","raw_affiliation_strings":["Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan","Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405286036"]},{"raw_affiliation_string":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025801731","display_name":"Shozo Osera","orcid":"https://orcid.org/0000-0002-4272-6358","observed_orcids":["https://orcid.org/0000-0002-4272-6358"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shozo Osera","raw_affiliation_strings":["Department of Gastroenterology Endoscopy, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology Endoscopy, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073312745","display_name":"Masaoki Sasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaoki Sasaki","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031871407","display_name":"Yuko Mori","orcid":"https://orcid.org/0000-0003-1919-2463","observed_orcids":["https://orcid.org/0000-0003-1919-2463"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuko Mori","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089050410","display_name":"Satoshi Hashigaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Hashigaki","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051179799","display_name":"Takashi Nagasawa","orcid":"https://orcid.org/0000-0002-1600-1062","observed_orcids":["https://orcid.org/0000-0002-1600-1062"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Nagasawa","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080897827","display_name":"Yoshiko Umeyama","orcid":"https://orcid.org/0000-0003-4967-0382","observed_orcids":["https://orcid.org/0000-0003-4967-0382"]},"institutions":[{"id":"https://openalex.org/I4210148786","display_name":"Pfizer (Japan)","ror":"https://ror.org/05pm71w80","country_code":"JP","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210148786"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiko Umeyama","raw_affiliation_strings":["Pfizer Japan Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Japan Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210148786"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062748030","display_name":"Takayuki Yoshino","orcid":"https://orcid.org/0000-0002-0489-4756","observed_orcids":["https://orcid.org/0000-0002-0489-4756"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takayuki Yoshino","raw_affiliation_strings":["Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5069272944"],"corresponding_institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4405285273","https://openalex.org/I4405286036"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":{"value":2600,"currency":"USD","value_usd":2600},"fwci":5.6931,"has_fulltext":true,"cited_by_count":97,"citation_normalized_percentile":{"value":0.97418878,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"107","issue":"6","first_page":"755","last_page":"763"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-4-6-inhibitors","display_name":"cyclin-dependent kinase 4/6 inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.8790000081062317},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.824999988079071},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8389999866485596},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7799999713897705},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.968999981880188},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8740000128746033},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7200000286102295},{"id":"https://openalex.org/keywords/rectal-cancer","display_name":"rectal cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/esophageal-cancer","display_name":"esophageal cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.8679999709129333},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.546999990940094},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9812647104263306},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.8718029856681824},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7579364776611328},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6427544355392456},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6164639592170715},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5894724130630493},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5272661447525024},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4895676076412201},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4472106099128723},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40365225076675415},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.39878594875335693},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3880147933959961},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3501346707344055},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.14434131979942322}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051358","descriptor_name":"Cyclin-Dependent Kinase 4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051361","descriptor_name":"Cyclin-Dependent Kinase 6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/cas.12932","doi":"https://doi.org/10.1111/cas.12932","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.12932","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12932","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3941987","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4968608","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26991823","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26991823","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:4968608","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4968608/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/cas.12932","doi":"https://doi.org/10.1111/cas.12932","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cas.12932","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12932","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2298692973.pdf","grobid_xml":"https://content.openalex.org/works/W2298692973.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W1464936406","https://openalex.org/W1985389450","https://openalex.org/W2012502745","https://openalex.org/W2132726386","https://openalex.org/W2136158663","https://openalex.org/W2137057588","https://openalex.org/W2144790402","https://openalex.org/W2148345265","https://openalex.org/W2153985422","https://openalex.org/W2154626333","https://openalex.org/W2265721697"],"related_works":["https://openalex.org/W2267775607","https://openalex.org/W3026119116","https://openalex.org/W2790211645","https://openalex.org/W2945956480","https://openalex.org/W7134973210","https://openalex.org/W2898684787","https://openalex.org/W4296904106","https://openalex.org/W2756972088","https://openalex.org/W2985624521","https://openalex.org/W2891869322"],"abstract_inverted_index":{"This":[0],"phase":[1],"I":[2],"study":[3],"in":[4,128,204,219,235,258],"Japanese":[5,259],"patients":[6,42,198,223],"evaluated":[7,59,85],"the":[8,79,134,149,240,249],"safety,":[9],"pharmacokinetics,":[10],"and":[11,19,33,62,116,194,212,227,247,254,268],"preliminary":[12],"efficacy":[13],"of":[14,40],"palbociclib,":[15],"a":[16],"highly":[17],"selective":[18],"reversible":[20],"oral":[21],"cyclin-dependent":[22],"kinase":[23],"4/6":[24],"inhibitor,":[25],"as":[26,37],"monotherapy":[27,253],"for":[28,252],"solid":[29],"tumors":[30],"(part":[31,55],"1)":[32],"combined":[34],"with":[35,43,123,133,141,207,214,265],"letrozole":[36,93,195,255],"first-line":[38],"treatment":[39],"postmenopausal":[41],"estrogen":[44],"receptor-positive,":[45],"human":[46],"epidermal":[47],"growth":[48],"factor":[49],"receptor":[50],"2-negative":[51],"advanced":[52],"breast":[53],"cancer":[54,209,216],"2).":[56],"Part":[57,83],"1":[58],"palbociclib":[60,86,117,193],"100":[61,110,144],"125":[63,113,142],"mg":[64,95,145],"once":[65],"daily":[66],"(3":[67],"weeks":[68,203],"on/1":[69],"week":[70],"off;":[71],"n":[72],"=":[73,97],"6":[74],"each":[75],"group)":[76],"to":[77],"determine":[78],"maximum":[80,87,170],"tolerated":[81,88,246],"dose.":[82,136],"2":[84],"dose":[89,242,251],"(125":[90],"mg)":[91],"plus":[92,118],"2.5":[94],"(n":[96],"6).":[98],"The":[99,261],"most":[100],"common":[101],"treatment-related":[102],"adverse":[103],"event":[104],"was":[105,139,186,245],"neutropenia":[106,130],"(all":[107],"grades/grade":[108],"3/4):":[109],"mg,":[111,114],"83%/67%;":[112],"67%/33%;":[115],"letrozole,":[119],"100%/83%.":[120],"Heavier":[121],"pretreatment":[122],"chemotherapy":[124],"may":[125],"have":[126],"resulted":[127],"higher":[129,140],"rates":[131],"observed":[132],"100-mg":[135],"Palbociclib":[137,238],"exposure":[138],"vs":[143,158,164,174,180],"(mean":[146],"area":[147],"under":[148],"plasma":[150,171],"concentration-time":[151],"curve":[152],"over":[153],"dosing":[154],"interval":[155],"[\u03c4]:":[156],"1322":[157],"547.5":[159],"ng\u00b7h/mL":[160,166],"[single":[161,177],"dose],":[162,178],"2838":[163],"1276":[165],"[multiple":[167,183],"dose];":[168],"mean":[169],"concentration:":[172],"104.1":[173],"41.4":[175],"ng/mL":[176,182],"185.5":[179],"77.4":[181],"dose]).":[184],"Half-life":[185],"23-26":[187],"h.":[188],"No":[189],"drug-drug":[190],"interactions":[191],"between":[192],"occurred.":[196],"Four":[197],"had":[199,224,229],"stable":[200,230],"disease":[201,231],"(\u226524":[202],"one":[205,213],"patient":[206],"rectal":[208],"[100":[210],"mg]":[211],"esophageal":[215],"[125":[217],"mg])":[218],"part":[220,236],"1;":[221],"two":[222,228],"partial":[225],"response":[226],"(both":[232],"\u226524":[233],"weeks)":[234],"2.":[237],"at":[239],"125-mg":[241],"(schedule":[243],"3/1)":[244],"is":[248],"recommended":[250],"combination":[256],"therapy":[257],"patients.":[260],"trials":[262],"are":[263],"registered":[264],"www.ClinicalTrials.gov:":[266],"A5481010":[267],"NCT01684215.":[269]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":13}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}